Published in
Dove Press, OncoTargets and Therapy, (Volume 14), p. 3037-3049, 2021
DOI: 10.2147/ott.s291801
Links
Tools
A Phase I Trial of the MET/ALK/ROS1 Inhibitor Crizotinib Combined with the VEGF Inhibitor Pazopanib in Patients with Advanced Solid Malignancies
Journal article published in 2021 by
Sarina A. Piha-Paul 
,
Ecaterina E. Dumbrava,
Binoj C. Nair,
Wendy Xiong,
Li Xu,
Rosa Mostorino,
Vivek Subbiah,
Nizar Tannir,
Siqing Fu,
Aung Naing,
Filip Janku,
Daniel D. Karp,
Shreyaskumar Patel,
Najat C. Daw ,
David Hong
and other authors.
,
Ecaterina E. Dumbrava,
Binoj C. Nair,
Wendy Xiong,
Li Xu,
Rosa Mostorino,
Vivek Subbiah,
Nizar Tannir,
Siqing Fu,
Aung Naing,
Filip Janku,
Daniel D. Karp,
Shreyaskumar Patel,
Najat C. Daw ,
David Hong
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Data provided by 